| Literature DB >> 33089738 |
Jeanine P D Guidry1, Lucinda L Austin2, Nicole H O'Donnell1, Ioana A Coman3, Alessandro Lovari4, Marcus Messner1.
Abstract
Influenza epidemics happen every year, with more than 8 million severe cases in 2017. The most effective way to prevent seasonal influenza is vaccination. In recent years, misinformation regarding vaccines abounds on social media, but the flu vaccine is relatively understudied in this area, and the current study is the first 1 to explore the content and nature of influenza information that is shared on Twitter, comparing tweets published in the early flu season with those posted in peak flu season. Using a quantitative content analysis, 1000 tweets from both parts of the flu season were analyzed for use of Health Belief Model (HBM) variables, engagement, and flu vaccine specific variables. Findings show several promising opportunities for health organizations and professionals: HBM constructs were present more frequently than in previous, related studies, and fewer vaccine-hesitant tweets appear to be present. However, the presence of high barriers to flu vaccine uptake increased significantly from early to peak season, including an increase in the mention of conspiracy theories. Flu vaccine related tweets appear to vary in misinformation level and density throughout the flu season. While this should be confirmed by further studies over multiple flu seasons, this a finding that should be considered by public health organizations when developing flu vaccine campaigns on social media.Entities:
Keywords: attitudes; health knowledge; human; influenza; influenza vaccines; practices; prevention; social media
Mesh:
Substances:
Year: 2020 PMID: 33089738 PMCID: PMC7585887 DOI: 10.1177/2150132720932722
Source DB: PubMed Journal: J Prim Care Community Health ISSN: 2150-1319
Flu Vaccine Descriptives for Twitter by Season.
| Variable/sub-variable | Early season | Peak season | Direction | Absolute percentage difference | 95% CI | |
|---|---|---|---|---|---|---|
|
|
|
| ||||
| Healthcare professionals oppose flu vaccine | .8% (n = 4) | 1.7% (n = 8) | increase | 0.9 | −0.005, 0.023 | .190 |
| Healthcare professionals promote flu vaccine | 25.1% (n = 131) | 18.8% (n = 90) | decrease | 6.3 | −0.115, −0.012 | .016 |
| Mistrust medical professionals | .6% (n = 3) | 6.5% (n = 31) | increase | 5.9 | 0.036, 0.082 | <.001 |
| Mistrust science | .2% (n = 1) | 3.1% (n = 15) | increase | 2.9 | 0.013, 0.045 | <.001 |
| Mistrust government | 2.1% (n = 11) | 7.1% (n = 34) | increase | 5.0 | 0.024, 0.076 | <.001 |
| Alternative protection against flu | 7.6% (n = 38) | 4.4% (n = 21) | decrease | 3.2 | −0.058, 0 | .025 |
| Specific target populations flu vaccine | 41.5% (n = 216) | 25.9% (n = 124) | decrease | 15.6 | −0.213, −.098 | <.001 |
|
|
|
| increase | 19.4 | 0.142, 0.0247 | <.001 |
| Primarily image | 38.9% (n = 131) | 35.2% (n = 142) | decrease | 3.7 | −0.106, 0.034 | |
| Primarily text | 11.9% (n = 40) | 11.9% (n = 48) | None | 0 | −0.046, 0.047 | |
| Mix of image and text | 31.8% (n = 104) | 34.0% (n = 137) | increase | 2.2 | −0.036, 0.099 | |
| Infographic | 3.6% (n = 12) | 1.7% (n = 7) | decrease | 1.9 | −0.042, 0.005 | |
| Drawing | 1.5% (n = 5) | 2.5% (n = 10) | increase | 1.0 | −0.010, 0.030 | |
| Video | 9.2% (n = 31) | 13.2% (n = 53) | increase | 4.0 | −0.006, 0.085 | |
| GIF | 2.4% (n = 8) | .2% (n = 1) | decrease | 2.2 | −0.038, −0.004 | |
| Other | .9% (n = 3) | 1.2% (n = 5) | increase | 0.3 | −0.011, 0.018 | |
|
|
|
| decrease | 1.7 | −0.043, 0.077 | .052 |
| Adult | 87.8% (n = 165) | 86.2% (n = 156) | decrease | 1.6 | −0.084, 0.053 | |
| (Pre)teen | 12.8% (n = 24) | 13.3% (n = 24) | increase | 0.5 | −.064, .074 | |
| Toddler/baby | 22.3% (n = 42) | 17.7% (n = 32) | decrease | 4.7 | −0.128, 0.035 | |
| Male | 58.5% (n = 110) | 42.0% (n = 76) | decrease | 16.5 | −0.266, −0.065 | |
| Female | 74.5% (n = 140) | 63.5% (n = 115) | decrease | 11 | −0.203, −0.016 | |
| White | 80.9% (n = 152) | 80.1% (n = 145) | decrease | 0.8 | −.088, 0.073 | |
| Black | 18.6% (n = 35) | 8.8% (n = 16) | decrease | 9.8 | −0.167, 0.028 | |
| Latinx | 4.8% (n = 9) | 1.7% (n = 3) | decrease | 3.1 | −0.067, 0.004 | |
| Asian | 8.0% (n = 15) | 4.4% (n = 8) | decrease | 3.6 | −0.085, 0.013 | |
| Medical professional | 28.7% (n = 54) | 24.9% (n = 45) | decrease | 3.8 | −0.129, 0.052 | |
|
|
|
| increase | 15.2 | 0.098, 0.205 | <.001 |
| Large needle | 31.4% (n = 11) | 35.0% (n = 36) | increase | 3.6 | −0.144, 0.214 | |
| Needle | 51.4% (n = 18) | 66.0% (n = 68) | increase | 14.6 | −0.043, 0.335 | |
| Brightly colored vaccine liquid | 5.7% (n = 2) | 1.0% (n = 1) | decrease | 4.7 | −0.127, 0.032 | |
| Scared facial expression | .0% (n = 0) | 4.9% (n = 5) | increase | 4.9 | 0.007, 0.090 | |
| Mask, gloves | 62.9% (n = 22) | 36.9% (n = 38) | decrease | 26 | −0.445, −0.074 | |
| Visual threat sign (skull, danger) | .0% (n = 0) | 2.9% (n = 3) | increase | 2.9 | −0.003, 0.062 | |
|
|
|
| increase | 17.5 | 0.115, 0.236 | <.001 |
| Blog: individual | .8% (n = 2) | .0% (n = 0) | decrease | 0.8 | −0.019, 0.003 | |
| Blog: individual, sole proprietor | .4% (n = 1) | .0% (n = 0) | decrease | 0.4 | −0.012, 0.004 | |
| Blog: organizational | .4% (n = 1) | .0% (n = 0) | decrease | 0.4 | −0.012, 0.004 | |
| Social media | 16.1% (n = 40) | 9.0% (n = 28) | decrease | 7.1 | −0.127, −0.016 | |
| Government/regulatory | 39.9% (n = 99) | 32.7% (n = 102) | decrease | 7.2 | −0.152, 0.008 | |
| Nonprofit website | 2.0% (n = 5) | .0% (n = 0) | decrease | 2.0 | −0.038, −0.003 | |
| Official medical | 5.6% (n = 14) | 6.4% (n = 20) | increase | 0.8 | −0.032, 0.047 | |
| Healthcare practitioner | .8% (n = 2) | .0% (n = 0) | decrease | 0.8 | −0.019, 0.003 | |
| Other health−focused | 3.6% (n = 9) | 5.4% (n = 17) | increase | 1.8 | −0.016, 0.052 | |
| Commercial (not health) | .4% (n = 1) | .6% (n = 2) | increase | 0.2 | −0.009, 0.014 | |
| Commercial health | 3.2% (n = 8) | 1.9% (n = 6) | decrease | 1.3 | −0.040, 0.014 | |
| News | 13.3% (n = 33) | 17.9% (n = 56) | increase | 4.6 | −0.014, 0.106 | |
| Academic | 4.4% (n = 11) | 14.1% (n = 44) | increase | 9.7 | 0.050, 0.143 | |
| Antivaccine organization | 2.4% (n = 6) | 6.4% (n = 20) | increase | 4.0 | 0.007, 0.073 | |
| Other | 5.6% (n = 14) | 4.8% (n = 15) | decrease | 0.8 | −0.046, 0.029 | |
| Broken link | .8% (n = 2) | .6% (n = 2) | decrease | 0.2 | −0.016, 0.013 | |
| Link to own site | 50.4% (n = 125) | 45.5% (n = 142) | decrease | 4.9 | −0.132, 0.034 |
Note. Bolded frequencies are totals in group and therefore the denominator for the subgroup in that section.
Significant at P < .05, using Chi Square tests; Fisher’s Exact Test if n < 5.
Flu Vaccine Related HBM Descriptives for Twitter by Season.
| Variable/sub-variable | Early season | Peak season | Direction | Absolute percentage difference | 95% CI | |
|---|---|---|---|---|---|---|
|
|
|
| ||||
|
| ||||||
| Perceived high benefits flu vaccine | 64.5% (n = 336) | 54.7% (n = 262) | decrease | 9.8 | −0.159, −0.037 | .002 |
| Perceived high barriers flu vaccine | 11.3% (n = 59) | 25.3% (n = 121) | increase | 14.0 | 0.092, 0.187 | <.001 |
| Perceived high severity flu | 42.0% (n = 219) | 34.7% (n = 166) | decrease | 7.3 | −0.134, −0.014 | .017 |
| Perceived susceptibility flu | 11.9% (n = 62) | 21.5% (n = 103) | increase | 9.6 | 0.050, 0.142 | <.001 |
| Cue to action - get flu vaccine | 69.1% (n = 360) | 53.2% (n = 255) | decrease | 15.9 | −0.218, −0.099 | <.001 |
| Self-efficacy - get flu vaccine | 28.2% (n = 147) | 16.1% (n = 77) | decrease | 12.1 | −0.172, −0.071 | <.001 |
|
| ||||||
| Severity: Flu serious | 40.5% (n = 211) | 33.0% (n = 158) | decrease | 7.5 | −0.135, −0.016 | .014 |
| Severity: Flu complications | 12.3% (n = 64) | 15.7% (n = 75) | increase | 3.4 | −0.009, 0.077 | .123 |
| Barriers: Flu vaccine deadly | 2.5% (n = 13) | 1.3% (n = 6) | decrease | 1.2 | −0.029, 0.004 | .150 |
| Barriers: Flu vaccine does not work | 3.6% (n = 19) | 11.5% (n = 35) | increase | 7.9 | 0.008, 0.065 | <.001 |
| Barriers: Mistrust flu vaccine safety | 5.8% (n = 30) | 11.7% (n = 56) | increase | 5.9 | 0.024, 0.094 | .001 |
| Barriers: Civil liberties related to flu vaccine | .6% (n = 3) | 1.9% (n = 9) | increase | 1.3 | −0.001, 0.027 | .059 |
|
|
|
| increase | 10.6 | 0.070, 0.141 | <.001 |
| Government | 40.0% (n = 8) | 37.7% (n = 26) | decrease | 2.3 | −0.266, 0.220 | |
| Medical | 15.0% (n = 3) | 46.4% (n = 32) | increase | 31.4 | 0.118, 0.510 | |
| Pharmaceutical | 30.0% (n = 6) | 55.1% (n = 38) | increase | 25.1 | 0.018, 0.483 | |
|
|
|
| increase | 4.1 | 0.012, 0.070 | .006 |
| Rash | 0.0% (n = 0) | 5.3% (n = 2) | increase | 5.3 | −0.018, 0.124 | |
| Shortness of breath | 10.0% (n = 2) | 2.6% (n = 1) | decrease | 7.4 | −0.215, 0.067 | |
| Autism symptoms/diagnosis | .0% (n = 0) | 15.8% (n = 6) | increase | 15.8 | 0.042, 0.274 | |
| Paralysis | 30.0% (n = 6) | 21.1% (n = 8) | decrease | 8.9 | −0.329, .150 | |
| Death | 60.0% (n = 12) | 15.8% (n = 6) | decrease | 44.2 | −0.686, −0.198 | |
| Fever | 5.0% (n = 1) | 2.6% (n = 1) | decrease | 2.4 | −0.132, 0.085 | |
| Other | 50% (n = 10) | 73.7% (n = 28) | increase | 23.7 | −0.023, 0.497 | |
Note. Bolded frequencies are totals in group and therefore the denominator for the subgroup in that section.
Significant at P < .05, using Chi Square tests; Fisher’s Exact Test if n < 5.
Logistic Regression.
| Variable |
| SE | Wald X2 |
| OR | 95% CI |
|---|---|---|---|---|---|---|
| HBM: Perceived benefits flu vax | 0.284 | 0.207 | 1.880 | .170 | 1.328 | 0.885, 1.992 |
| HBM: Perceived barriers flu vax | 0.739 | 0.221 | 11.164 | .001 | 2.094 | 1.357, 3.232 |
| HBM: Flu susceptibility | 0.758 | 0.207 | 13.476 | <.001 | 2.135 | 1.424, 3.200 |
| HBM: Flu severity | −0.050 | 0.181 | 0.077 | .782 | 0.951 | 0.667, 1.356 |
| HBM: Flu vax uptake self-efficacy | −0.615 | 0.182 | 11.477 | .001 | 0.541 | 0.379, 0.772 |
| HBM: Flu vax cue to action | −0.371 | 0.213 | 3.037 | .081 | 0.690 | 0.455, 1.047 |
| Web link | 0.290 | 0.145 | 3.975 | .046 | 1.336 | 1.005, 1.776 |
| Visual | 1.029 | 0.173 | 35.429 | <.001 | 2.798 | 1.994, 3.927 |
| Healthcare professionals promoting flu vax | −0.227 | 0.172 | 1.746 | .186 | 0.797 | 0.569, 1.116 |
| Alternative protection | 0.606 | 0.417 | 2.114 | .146 | 1.833 | 0.810, 4.149 |
| Specific populations for flu vax | −0.343 | 0.173 | 3.949 | .047 | 0.710 | 0.506, 0.995 |
Significant at P < .05.
Dichotomous Independent Variables and Median Engagement on Twitter.
| Engagement variable | Season | Variable | Median present | Median absent | U | |
|---|---|---|---|---|---|---|
| Retweets | Early | Visual | 2.00 | 0.00 | 41 782.000 | <.001 |
| Likes | Early | Visual | 3.00 | 0.00 | 41 215.500 | <.001 |
| Retweets | Early | Web link | 2.00 | 0.00 | 41 261.500 | <.001 |
| Likes | Early | Web link | 2.00 | 1.00 | 38 827.500 | .003 |
| Retweets | Early | Healthcare professionals promote flu vax | 2.00 | 1.00 | 30 079.500 | .002 |
| Likes | Early | Healthcare professionals promote flu vax | 4.00 | 1.00 | 31 475.500 | <.001 |
| Retweets | Early | Specific populations flu vax | 0.50 | 1.00 | 27 869.500 | .002 |
| Likes | Early | Specific populations flu vax | 0.00 | 3.00 | 24 632.500 | <.001 |
| Retweets | Peak | Healthcare professionals promote flu vax | 2.00 | 0.00 | 20 980.000 | .001 |
| Likes | Peak | Healthcare professionals promote flu vax | 2.00 | 0.00 | 21 267.500 | .001 |
| Retweets | Early | Flu susceptibility | 4.50 | 1.00 | 17 375.500 | .003 |
| Likes | Early | Flu susceptibility | 6.00 | 2.00 | 17 032.000 | .009 |
| Retweets | Early | Flu vax uptake self-efficacy | 3.00 | 1.00 | 32 992.000 | <.001 |
| Likes | Early | Flu vax uptake self-efficacy | 4.00 | 1.00 | 32 687.000 | .001 |
| Retweets | Peak | Flu vax uptake self-efficacy | 2.00 | 1.00 | 18 030.000 | .013 |